Century Therapeutics Ownership | Who Owns Century Therapeutics?
Century Therapeutics Ownership Summary
Century Therapeutics is owned by 23.52% institutional investors, 27.28% insiders, and 49.20% retail investors. Boxer capital is the largest institutional shareholder, holding 7.87% of IPSC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.49% of its assets in Century Therapeutics shares.
IPSC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Century Therapeutics | 23.52% | 27.28% | 49.20% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Boxer capital | 4.90M | 7.87% | $12.50M |
| Blackrock | 2.90M | 4.65% | $7.38M |
| Bain capital life sciences investors | 3.54M | 4.10% | $1.76M |
| Renaissance | 2.59M | 3.00% | $1.29M |
| Vanguard group | 2.10M | 2.44% | $1.05M |
| Dafna capital management | 1.70M | 1.98% | $848.71K |
| Casdin capital | 1.23M | 1.42% | $611.64K |
| Syncona portfolio | 1.21M | 1.41% | $604.10K |
| Two sigma investments, lp | 911.45K | 1.06% | $453.90K |
| Tang capital management | 900.00K | 1.04% | $448.20K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Syncona portfolio | 1.21M | 2.18% | $604.10K |
| Boxer capital | 4.90M | 0.66% | $12.50M |
| Superstring capital management lp | 462.96K | 0.23% | $230.56K |
| Dafna capital management | 1.70M | 0.21% | $848.71K |
| Bain capital life sciences investors | 3.54M | 0.12% | $1.76M |
| Casdin capital | 1.23M | 0.05% | $611.64K |
| Gsa capital partners llp | 603.48K | 0.03% | $301.00K |
| Parametrica management | 27.84K | 0.02% | $13.86K |
| Tang capital management | 900.00K | 0.02% | $448.20K |
| Harbourvest partners | 29.02K | 0.01% | $14.45K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Boxer capital | 4.90M | 0.66% | 3.15M |
| Blackrock | 2.90M | 0.00% | 1.40M |
| Renaissance | 2.59M | 0.00% | 564.40K |
| Two sigma advisers, lp | 857.60K | 0.00% | 490.50K |
| Acadian asset management | 719.81K | 0.00% | 412.71K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vr adviser | - | - | -2.50M |
| Bain capital life sciences investors | 3.54M | 0.12% | -1.87M |
| Millennium management | - | - | -1.61M |
| Adage capital partners gp | - | - | -1.32M |
| Avidity partners management lp | - | - | -1.22M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Lazard asset management | 62.95K | - | 62.95K | $35.00K |
| Susquehanna group, llp | 33.40K | - | 33.40K | $33.73K |
| Abel hall | 17.58K | 0.00% | 17.58K | $9.82K |
| Srs capital advisors | 99.00 | - | 99.00 | $49.00 |
| Optiver b.v. | 32.00 | - | 32.00 | $16.00 |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -6.00 |
| Capital performance advisors llp | -12.00 |
| Gamma investing | -131.00 |
| True wealth design | -266.00 |
| Advisor group | -360.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 51 | -16.39% | 20,279,909 | -7.85% | 23 | 3.59% | 15 | -55.88% | 23 | 21.05% |
| Jun 30, 2025 | 66 | -4.35% | 22,628,552 | -20.19% | 26 | 2.42% | 37 | 60.87% | 20 | -31.03% |
| Mar 31, 2025 | 70 | -5.41% | 29,566,395 | -18.77% | 34 | 1.86% | 23 | -48.89% | 29 | 190.00% |
| Dec 31, 2024 | 74 | 8.82% | 36,399,688 | -8.20% | 42 | 1.96% | 44 | 41.94% | 10 | -37.50% |
| Sep 30, 2024 | 68 | 11.48% | 39,649,236 | -1.17% | 46 | 1.96% | 31 | -20.51% | 16 | 33.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.29M | 1.49% | -28.12K |
| Fidelity Growth Compy Commingled Pl O | 1.22M | 1.45% | -96.60K |
| Syncona Ord | 1.21M | 1.43% | 212.28K |
| Vanguard Institutional Extnd Mkt Idx Tr | 539.66K | 0.63% | -245.91K |
| Fidelity Small Cap Index | 480.13K | 0.56% | - |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 366.83K | 0.43% | - |
| State St Russell Sm/Mid Cp® Indx SL Cl I | 366.83K | 0.43% | - |
| Federated Hermes Kaufmann Growth | 267.75K | 0.32% | - |
| Federated Hermes Kaufmann R | 267.75K | 0.32% | - |
| Vanguard Russell 2000 ETF | 229.84K | 0.27% | 2.12K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 12, 2025 | Pfeiffenberger Brent | President and CEO | Buy | $30.35K |
| Dec 08, 2025 | Carr Douglas | SVP Finance & Operations | Sell | $136.72 |
| Dec 08, 2025 | Russotti Gregory | See Remarks | Sell | $279.83 |
| Nov 20, 2025 | Cowan Chad | Chief Scientific Officer | Sell | $2.74K |
| Nov 19, 2025 | Pfeiffenberger Brent | President and CEO | Buy | $17.33K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | 1 | 5 |
| 2025 Q3 | - | 4 |
| 2025 Q2 | - | 7 |
| 2025 Q1 | - | 7 |
| 2024 Q4 | - | 2 |
IPSC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools